Matches in SemOpenAlex for { <https://semopenalex.org/work/W3048398163> ?p ?o ?g. }
- W3048398163 endingPage "472" @default.
- W3048398163 startingPage "464" @default.
- W3048398163 abstract "Aim The purpose of the present study is to explore the anti-inflammatory potential of risperidone in acetic acid-induced rat colitis through inhibition of TLR4/NF-kB pathway.Methods Acute colitis induction was done by intra-rectal administration of 2 mL of 4% diluted acetic acid solution. Two h after colitis induction, dexamethasone (2 mg/kg) as standard drugorrisperidone (2, 4 and 6 mg/kg) were administered orally to wistar rats for five consecutive days. 24 h after the last treatment, animals were sacrificed by cervical dislocation. Macroscopic and microscopic damage evaluation was done. Biochemical and ELISA methods were used to assess myeloid peroxidase (MPO) enzyme activity and tumor necrosis factor-α (TNF-α) level respectively. Moreover, immunohistochemistry (IHC) was performed to detect the expression of TLR4 and pNF-kBproteins.Results Dexamethasone (2 mg/kg) or risperidone (2, 4 and 6 mg/kg) improved acetic acid-induced macroscopic (p < .001) and microscopic lesions. Additionally, risperidone (2, 4 and 6 mg/kg) inhibited the activity of MPO and TNF-α (p < .01, p < .001) in the colon tissue compared to acetic acid group. Furthermore, bothdexamethasone and risperidone (2, 4 and 6 mg/kg) significantly reduced acetic acid-induced expression of TLR4and pNF-kB proteins (p < .05, p < .01, p < .001).Conclusion The anti-inflammatory effect of risperidone on acetic acid-induced colitis in rats may involve inhibition of TLR4 and NF-kB signaling pathway." @default.
- W3048398163 created "2020-08-18" @default.
- W3048398163 creator A5003131492 @default.
- W3048398163 creator A5013567786 @default.
- W3048398163 creator A5034729928 @default.
- W3048398163 creator A5035204618 @default.
- W3048398163 creator A5038181116 @default.
- W3048398163 creator A5040994499 @default.
- W3048398163 creator A5066522779 @default.
- W3048398163 date "2020-08-25" @default.
- W3048398163 modified "2023-09-30" @default.
- W3048398163 title "Risperidone attenuates acetic acid-induced colitis in rats through inhibition of TLR4/NF-kB signaling pathway" @default.
- W3048398163 cites W1821112440 @default.
- W3048398163 cites W1906569767 @default.
- W3048398163 cites W1997070257 @default.
- W3048398163 cites W2003085334 @default.
- W3048398163 cites W2003630839 @default.
- W3048398163 cites W2004608617 @default.
- W3048398163 cites W2004773897 @default.
- W3048398163 cites W2006453091 @default.
- W3048398163 cites W2019713032 @default.
- W3048398163 cites W2020358486 @default.
- W3048398163 cites W2022670141 @default.
- W3048398163 cites W2047797335 @default.
- W3048398163 cites W2059149560 @default.
- W3048398163 cites W2060627189 @default.
- W3048398163 cites W2084422721 @default.
- W3048398163 cites W2087834892 @default.
- W3048398163 cites W2106225676 @default.
- W3048398163 cites W2121908572 @default.
- W3048398163 cites W2123130757 @default.
- W3048398163 cites W2130023894 @default.
- W3048398163 cites W2131724495 @default.
- W3048398163 cites W2136962131 @default.
- W3048398163 cites W2138386511 @default.
- W3048398163 cites W2143741032 @default.
- W3048398163 cites W2145028653 @default.
- W3048398163 cites W2166114661 @default.
- W3048398163 cites W2168485813 @default.
- W3048398163 cites W2168644074 @default.
- W3048398163 cites W2206260065 @default.
- W3048398163 cites W2318276736 @default.
- W3048398163 cites W2335196723 @default.
- W3048398163 cites W2623192675 @default.
- W3048398163 cites W2766119448 @default.
- W3048398163 cites W2805603575 @default.
- W3048398163 cites W2980406646 @default.
- W3048398163 doi "https://doi.org/10.1080/08923973.2020.1808987" @default.
- W3048398163 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32787472" @default.
- W3048398163 hasPublicationYear "2020" @default.
- W3048398163 type Work @default.
- W3048398163 sameAs 3048398163 @default.
- W3048398163 citedByCount "10" @default.
- W3048398163 countsByYear W30483981632021 @default.
- W3048398163 countsByYear W30483981632022 @default.
- W3048398163 countsByYear W30483981632023 @default.
- W3048398163 crossrefType "journal-article" @default.
- W3048398163 hasAuthorship W3048398163A5003131492 @default.
- W3048398163 hasAuthorship W3048398163A5013567786 @default.
- W3048398163 hasAuthorship W3048398163A5034729928 @default.
- W3048398163 hasAuthorship W3048398163A5035204618 @default.
- W3048398163 hasAuthorship W3048398163A5038181116 @default.
- W3048398163 hasAuthorship W3048398163A5040994499 @default.
- W3048398163 hasAuthorship W3048398163A5066522779 @default.
- W3048398163 hasConcept C118552586 @default.
- W3048398163 hasConcept C126322002 @default.
- W3048398163 hasConcept C134018914 @default.
- W3048398163 hasConcept C17991360 @default.
- W3048398163 hasConcept C185592680 @default.
- W3048398163 hasConcept C2775862500 @default.
- W3048398163 hasConcept C2776070231 @default.
- W3048398163 hasConcept C2776412080 @default.
- W3048398163 hasConcept C2776673659 @default.
- W3048398163 hasConcept C2780057945 @default.
- W3048398163 hasConcept C2780401358 @default.
- W3048398163 hasConcept C55493867 @default.
- W3048398163 hasConcept C62478195 @default.
- W3048398163 hasConcept C71924100 @default.
- W3048398163 hasConcept C98274493 @default.
- W3048398163 hasConceptScore W3048398163C118552586 @default.
- W3048398163 hasConceptScore W3048398163C126322002 @default.
- W3048398163 hasConceptScore W3048398163C134018914 @default.
- W3048398163 hasConceptScore W3048398163C17991360 @default.
- W3048398163 hasConceptScore W3048398163C185592680 @default.
- W3048398163 hasConceptScore W3048398163C2775862500 @default.
- W3048398163 hasConceptScore W3048398163C2776070231 @default.
- W3048398163 hasConceptScore W3048398163C2776412080 @default.
- W3048398163 hasConceptScore W3048398163C2776673659 @default.
- W3048398163 hasConceptScore W3048398163C2780057945 @default.
- W3048398163 hasConceptScore W3048398163C2780401358 @default.
- W3048398163 hasConceptScore W3048398163C55493867 @default.
- W3048398163 hasConceptScore W3048398163C62478195 @default.
- W3048398163 hasConceptScore W3048398163C71924100 @default.
- W3048398163 hasConceptScore W3048398163C98274493 @default.
- W3048398163 hasFunder F4320322670 @default.
- W3048398163 hasIssue "5" @default.
- W3048398163 hasLocation W30483981631 @default.
- W3048398163 hasOpenAccess W3048398163 @default.